期刊文献+

MTRR基因A66G多态性及血浆同型半胱氨酸水平与心肌梗死的关系 被引量:4

The relationship of polymorphisms of methionine synthase reductase gene and plasma homocysteine levels with myocardial infarction
下载PDF
导出
摘要 目的研究MTRR多态性及血浆同型半胱氨酸(Hcy)水平与心肌梗死的关系。方法运用聚合酶链反应-限制性片段长度多态性技术(PCR-RFLP)检测180例心肌梗死患者及180例冠状动脉正常的人MTRR基因多态性,用高效液相色谱仪和荧光检测仪测定血浆总Hcy水平。结果 MTRR有3种基因型,即纯合子突变型(GG)、杂合子突变型(AG)及正常野生型(AA)。心肌梗死组GG型频率为35.4%,AG型频率为53.8%,AA型频率为10.8%,G等位基因频率为62.3%,A等位基因频率为37.7%。正常组中GG型频率为20.1%,AG型频率为55.8%,AA型频率为24.1%,G等位基因频率为32.1%,A等位基因频率为67.9%,且心肌梗死组GG型频率高于正常组(P<0.01)。正常人群中GG基因型者血浆总Hcy水平明显高于(AA+AG)基因型者(P<0.01)。心肌梗死患者血浆总Hcy水平显著高于正常组(P<0.01)。多因素分析显示,MTRR基因突变型GG可能是心肌梗死发病的一个危险因素。结论 MTRR GG基因型突变可能升高个体血浆总Hcy水平;MTRR可能是心肌梗死的易感基因之一;MTRR基因突变型及高Hcy血症可能是心肌梗死发病的一个危险因素。 Objective To study the relationship of polymorphisms of methionine synthase reductase(MTRR)gene and plasma homcysteine(Hcy)levels with myocardial infarction.Methods 180 myocaedial infarction patients and 180 coronary artery normal subjects were included in the study.The polymorphisms of their MTRR gene were analyzed by PCR-RFLP and their plasma total Hcy levels were measured by high-performance liquid chromatography and fluorescence detection methods.Results There were three kinds of genotype:GG(homozygous mytation),AG(heterozygous mutation)and AA(wild-type).The frequencies of the three genotypes were as follows:GG,35.4%;AG,53.8% and AA,10.8% in mypcardial indarction patients.Meanwhile,GG,20.1%;AG,55.8%;AA,24.1% in coronary artery normal subjects,respectively.The frequency of G alleles was significantly higher in myocardial infarction patients than that in normal controls(62.3% and 32.1%,respectively)(P〈0.01).Mean total plasma homoctsteine concentrations were significantly higher in myocardial infarction patients than that in the normal subjects(P〈0.01).Conclusion These results suggest that polymotphisms of MTRR gene and/or hyperhomocysteinemia may be an independent risk factor for myocardial infarction.
作者 笪伟 刘和俊
出处 《安徽医科大学学报》 CAS 北大核心 2011年第5期467-470,共4页 Acta Universitatis Medicinalis Anhui
关键词 心肌梗死 多态性 单核苷酸 半胱氨酸/血液 myocardial infarction polymorphism single nucleotide cysteine/blood
  • 相关文献

参考文献11

  • 1Ridker P M,Shih J, Cook T J,et at. Plasma homocysteine concen- tration,statin therapy, and the risk of first acute coronary events [ J ]. Circulation ,2002,105 ( 15 ) : 1776 - 9.
  • 2Stuhlinger M C ,Tsao P S,Her J H ,et al. Homocysteine impairs the nitric oxide synthase pathway:role of asymmetrie dimethylarginine [ J ]. Circulation,2001,104 ( 21 ) : 2569 - 75.
  • 3Speidl W S, Nikfardjam M, Niessner A, et al. Mild hyperhomocys-teinemia is associated with a deereased fibrinolytic activity in pa-tients after ST-elevation myocardial infaraction [ J ]. Thromb Res, 2007,119(3) :331 -6.
  • 4O, Leafy V B , Mills J L, Pangilinan F, et al. Analysis of methio- nine synthase reduetase polymorphisms for neural tube defects risk association [ J ]. Mol Genet Metab ,2005,85 ( 3 ) :220 - 7.
  • 5Undas A, Brozek J, Szczeklik A. Homocystcine and thrombosis: from basic science to clinical evidence [ J ]. Thromb Haemost, 2005,94 ( 5 ) :907 - 15.
  • 6Hirche F,Schr? der A, Knoth B,et al. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expres- sion of hepatic genes involved in cholesterol metabolism[ J]. Br J Nutr,2006,95 ( 5 ) : 879 - 88.
  • 7Liao D,Tan H, Hui R, et al. Hyperhomocy steinemia decreases cir- culating high-density lipoprotein by inhibiting apotipoprntein A-I protein synthesis and enhancing HDL cholesterol clearance [ J ]. Circ Rcs,2006,99(6) :598 -606.
  • 8Wilson K M, McCaw R B, Leo L, ct al. Prothrombotic effects of hy- perhomocysteinemia and hypereholesterolemia in APOE-deficient mice [ J ]. Arterioscler Thromb Vasc Biol, 2007,27 ( 1 ) :233 - 40.
  • 9De Vriese A S, Langlois M, Bernard D, et al. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialys- is patients [ J ]. Nephrol Dial Transplant, 2003 , 18 ( 12 ) : 2596 - 600.
  • 10Gaughan D J, Kluijtmans L A, Barbaux S, et al. The methionine synthase reductasc(MTRR) A66G polymorphism is a novel genetic determinant of plasma homocyvsteine concemrations[ J]. Atheroscle- rosis,2001 ,157(2) :451 -6.

同被引文献59

  • 1王伟华,郭栋,王凤菊.MTRR基因A66G多态性与动脉粥样硬化性脑梗塞的相关性研究[J].中国优生与遗传杂志,2008,16(10):21-22. 被引量:2
  • 2杜子明,黄爱玲,柳息洪.人蛋氨酸合成酶还原酶A66G基因突变频率的检测[J].解剖学研究,2004,26(2):112-114. 被引量:3
  • 3徐恩,邓兵梅,陈盛强,谢海峰,陆雪芬.MTRR A66G、MSD919G、MTHFR C677T基因多态性与脑梗死的关系[J].中华神经医学杂志,2005,4(9):902-904. 被引量:4
  • 4Swanson DA, Liu ML, Baker PJ, et al. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol,2001,21:1058-1065.
  • 5Elmore CL, Wu X, Leclerc D, et al. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol Genet Metab,2007 ,91:85-97.
  • 6Rosenblatt DS, Cooper BA, Pottier A, et al. Altered vitamin B12 metabolism in fibroblasts from a patient with rnegaloblastic anemia and homocystinuria due to a new defect in metbionine biosynthesis. J Clin Invest,1984,74:2149-2156.
  • 7Steen C, Rosenblatt DS, Scheying H, et al. Cobalamin E (cblE) disease :a severe neurological disorder with megaloblastic anaemia, homocystinuria and low serum methionine. J Inherit Metab Dis, 1997,20 : 705 -706.
  • 8Zavad6kova P, Fowler B, Suormala T, et al. cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat, 2005, 25:239-247.
  • 9Matthews RG, Elmore CL. Defects in homocysteine metabolism: diversity among hyperhomocystinemias. Clin Chem Lab Med, 2007,45 : 1700-1703.
  • 10Desouza C, Keebler M, McNamara DB, et al. Drugs -fecting homocysteine metabolism:impact on cardiovascular risk. Drugs, 2002,62:605616.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部